Sylvie Burnouf

1.8k total citations
19 papers, 728 citations indexed

About

Sylvie Burnouf is a scholar working on Physiology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Sylvie Burnouf has authored 19 papers receiving a total of 728 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Physiology, 9 papers in Cellular and Molecular Neuroscience and 6 papers in Pharmacology. Recurrent topics in Sylvie Burnouf's work include Alzheimer's disease research and treatments (14 papers), Cholinesterase and Neurodegenerative Diseases (6 papers) and Neuroscience and Neuropharmacology Research (5 papers). Sylvie Burnouf is often cited by papers focused on Alzheimer's disease research and treatments (14 papers), Cholinesterase and Neurodegenerative Diseases (6 papers) and Neuroscience and Neuropharmacology Research (5 papers). Sylvie Burnouf collaborates with scholars based in France, Germany and United Kingdom. Sylvie Burnouf's co-authors include David Blum, Luc Buée, Linda Partridge, Jacqueline Dols, Dominique Demeyer, Malika Hamdane, Karim Bélarbi, Marie‐Eve Grosjean, Raphaëlle Caillierez and Laëtitia Troquier and has published in prestigious journals such as Diabetes, Scientific Reports and Acta Neuropathologica.

In The Last Decade

Sylvie Burnouf

19 papers receiving 722 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sylvie Burnouf France 15 399 263 213 130 120 19 728
Huixin Xu United States 12 402 1.0× 325 1.2× 226 1.1× 251 1.9× 93 0.8× 24 878
Rea Pihlaja Finland 10 264 0.7× 147 0.6× 221 1.0× 251 1.9× 97 0.8× 11 641
Yifeng Du United States 17 211 0.5× 194 0.7× 369 1.7× 211 1.6× 129 1.1× 22 938
Ana Gómez Spain 15 274 0.7× 309 1.2× 291 1.4× 94 0.7× 170 1.4× 30 1.1k
Lakshman Puli Finland 11 422 1.1× 268 1.0× 238 1.1× 202 1.6× 130 1.1× 14 883
Valérie Suain Belgium 17 608 1.5× 209 0.8× 324 1.5× 210 1.6× 140 1.2× 22 882
Dolores Del Prete United States 12 484 1.2× 290 1.1× 392 1.8× 107 0.8× 144 1.2× 18 858
Makis Tzioras United Kingdom 8 334 0.8× 196 0.7× 211 1.0× 219 1.7× 74 0.6× 11 674
Eiron Cudaback United States 15 251 0.6× 201 0.8× 207 1.0× 199 1.5× 345 2.9× 22 812
Farida El Gaamouch United States 10 205 0.5× 315 1.2× 275 1.3× 121 0.9× 57 0.5× 11 637

Countries citing papers authored by Sylvie Burnouf

Since Specialization
Citations

This map shows the geographic impact of Sylvie Burnouf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvie Burnouf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvie Burnouf more than expected).

Fields of papers citing papers by Sylvie Burnouf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvie Burnouf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvie Burnouf. The network helps show where Sylvie Burnouf may publish in the future.

Co-authorship network of co-authors of Sylvie Burnouf

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvie Burnouf. A scholar is included among the top collaborators of Sylvie Burnouf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvie Burnouf. Sylvie Burnouf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Burnouf, Sylvie, Oyinkan Sofola-Adesakin, Jacqueline Dols, et al.. (2017). Pseudo-acetylation of multiple sites on human Tau proteins alters Tau phosphorylation and microtubule binding, and ameliorates amyloid beta toxicity. Scientific Reports. 7(1). 9984–9984. 27 indexed citations
2.
Burnouf, Sylvie, et al.. (2016). Acetylation mimic of lysine 280 exacerbates human Tau neurotoxicity in vivo. Scientific Reports. 6(1). 22685–22685. 62 indexed citations
3.
Burnouf, Sylvie, Sebastian Grönke, Hrvoje Augustin, et al.. (2016). Deletion of endogenous Tau proteins is not detrimental in Drosophila. Scientific Reports. 6(1). 23102–23102. 34 indexed citations
4.
Burnouf, Sylvie, et al.. (2015). Aβ43 is neurotoxic and primes aggregation of Aβ40 in vivo. Acta Neuropathologica. 130(1). 35–47. 37 indexed citations
5.
Ahmed, Tariq, David Blum, Sylvie Burnouf, et al.. (2014). Rescue of impaired late–phase long-term depression in a tau transgenic mouse model. Neurobiology of Aging. 36(2). 730–739. 28 indexed citations
6.
Fernández-Gómez, Francisco-José, Fanny Jumeau, Maxime Derisbourg, et al.. (2014). Consensus Brain-derived Protein, Extraction Protocol for the Study of Human and Murine Brain Proteome Using Both 2D-DIGE and Mini 2DE Immunoblotting. Journal of Visualized Experiments. 5 indexed citations
7.
Laurent, Cyril, Joana E. Coelho, Ursula S. Sandau, et al.. (2014). From epidemiology to pathophysiology: what about caffeine in Alzheimer's disease?. Biochemical Society Transactions. 42(2). 587–592. 34 indexed citations
8.
Fernández-Gómez, Francisco-José, Fanny Jumeau, Maxime Derisbourg, et al.. (2014). Consensus Brain-derived Protein, Extraction Protocol for the Study of Human and Murine Brain Proteome Using Both 2D-DIGE and Mini 2DE Immunoblotting. Journal of Visualized Experiments. 1 indexed citations
9.
Leboucher, Antoine, Cyril Laurent, Francisco-José Fernández-Gómez, et al.. (2012). Detrimental Effects of Diet-Induced Obesity on τ Pathology Are Independent of Insulin Resistance in τ Transgenic Mice. Diabetes. 62(5). 1681–1688. 80 indexed citations
10.
Burnouf, Sylvie, Alberto Martire, Maxime Derisbourg, et al.. (2012). NMDA receptor dysfunction contributes to impaired brain‐derived neurotrophic factor‐induced facilitation of hippocampal synaptic transmission in a Tau transgenic model. Aging Cell. 12(1). 11–23. 57 indexed citations
11.
Burnouf, Sylvie, Karim Bélarbi, Laëtitia Troquier, et al.. (2012). Hippocampal BDNF Expression in a Tau Transgenic Mouse Model. Current Alzheimer Research. 9(4). 406–410. 10 indexed citations
12.
Bélarbi, Karim, Sylvie Burnouf, Francisco-José Fernández-Gómez, et al.. (2011). Loss of Medial Septum Cholinergic Neurons in THY-Tau22 Mouse Model: What Links with tau Pathology?. Current Alzheimer Research. 8(6). 633–638. 29 indexed citations
13.
Burnouf, Thierry, et al.. (2011). Human platelet concentrates: a source of solvent/detergent‐treated highly enriched brain‐derived neurotrophic factor. Transfusion. 52(8). 1721–1728. 27 indexed citations
14.
Troquier, Laëtitia, Raphaëlle Caillierez, Sylvie Burnouf, et al.. (2011). P2‐533: Targeting phospho‐Ser422 by active Tau immunotherapy in THY‐Tau22, a suitable therapeutic approach. Alzheimer s & Dementia. 7(4S_Part_14). 4 indexed citations
15.
Buée, Luc, Laëtitia Troquier, Sylvie Burnouf, et al.. (2010). From tau phosphorylation to tau aggregation: what about neuronal death?. Biochemical Society Transactions. 38(4). 967–972. 85 indexed citations
16.
Jeugd, Ann Van der, Tariq Ahmed, Sylvie Burnouf, et al.. (2010). Hippocampal tauopathy in tau transgenic mice coincides with impaired hippocampus-dependent learning and memory, and attenuated late-phase long-term depression of synaptic transmission. Neurobiology of Learning and Memory. 95(3). 296–304. 73 indexed citations
17.
Ekiaby, Magdy El, Makram A. Sayed, Claudine Caron, et al.. (2009). Solvent-detergent filtered (S/D-F) fresh frozen plasma and cryoprecipitate minipools prepared in a newly designed integral disposable processing bag system. Transfusion Medicine. 20(1). 48–61. 47 indexed citations
18.
Bélarbi, Karim, Katharina Schindowski, Sylvie Burnouf, et al.. (2009). Early Tau Pathology Involving the Septo-Hippocampal Pathway in a Tau Transgenic Model: Relevance to Alzheimers Disease. Current Alzheimer Research. 6(2). 152–157. 38 indexed citations
19.
Popoli, Patrizia, David Blum, Maria Rosaria Domenici, Sylvie Burnouf, & Yijuang Chern. (2008). A Critical Evaluation of Adenosine A2A Receptors as Potentially “Druggable” Targets in Huntingtons Disease. Current Pharmaceutical Design. 14(15). 1500–1511. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Huixin Xu Breakdown of academic impact, for papers by Rea Pihlaja Breakdown of academic impact, for papers by Yifeng Du Breakdown of academic impact, for papers by Ana Gómez Breakdown of academic impact, for papers by Lakshman Puli Breakdown of academic impact, for papers by Valérie Suain Breakdown of academic impact, for papers by Dolores Del Prete Breakdown of academic impact, for papers by Makis Tzioras Breakdown of academic impact, for papers by Eiron Cudaback Breakdown of academic impact, for papers by Farida El Gaamouch
Rankless by CCL
2026